NCT01456663View on ClinicalTrials.gov

A Study to Evaluate the Pharmacokinetics of AFQ056 in Subjects With Hepatic Impairment Compared to Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Hepatic Impairment
Interventions
DRUG

AFQ056

Trial Locations (3)

8230

Novartis Investigative Site, Balatonfüred

10117

Novartis Investigative Site, Berlin

32809

Novartis Investigative Site, Orlando

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY